Vivani Medical, Inc.
VANI
$1.05
$0.021.94%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 2.42% | -2.86% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.39% | 11.05% | |||
| Operating Income | -2.39% | -11.05% | |||
| Income Before Tax | -0.15% | -12.79% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -0.15% | -12.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.15% | -12.79% | |||
| EBIT | -2.39% | -11.05% | |||
| EBITDA | -2.81% | -11.04% | |||
| EPS Basic | 3.57% | -12.33% | |||
| Normalized Basic EPS | 3.66% | -12.34% | |||
| EPS Diluted | 3.57% | -12.33% | |||
| Normalized Diluted EPS | 3.66% | -12.34% | |||
| Average Basic Shares Outstanding | 3.94% | 0.41% | |||
| Average Diluted Shares Outstanding | 3.94% | 0.41% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||